CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

B. Riley Initiates 4D Molecular Therapeutics at Buy With $37 Price Target

Positive
AI Analysis

Summary

B. Riley initiated coverage of 4D Molecular Therapeutics with a Buy rating and a $37 price target.

Importance:3/10
Sentiment:
0.60
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 31, 2026 1:33 PM

Read Original